The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Edwards Lifesciences Corp.  (EW) Trade Now »     Rate EW  -  Discuss EW  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate EW:



EW Analysis & Videos »


EW: Bull or Bear?

Edwards Lifesciences Corp. Graphic_rating_buy EW <> ...
Foto
62%
 +24.27%
in 484 days
Analysts'
 Recommendation: 		Buy  
    30 Days Ago: Buy  
  Analysts' Target: $58  
<> <>
Analysts' Targets
 Stanford Group Company $69 
By  Marian Filo   (-24.55%  risk: aggressive)  07/13/08 Comment


Trading Ideas Edwards LifeSciences (EW) Heart Healthy and Portfolio Strong Graphic_rating_buy EW
Cc_logo
49%
 +0.00%
in 3 hours
(closed on 05/08/08)
Edwards LifeSciences (EW) is an interesting small/mid cap play in this market. First off, the company provides products and technologies designed to treat cardiovascular diseases. It focuses primarily on heart valve disease, peripheral vascular disease, and critical care technologies. On April 22, the company raised its full-year sales and earnings guidance, citing strength in each of [...]
By  The Correct Call   (+0.02%  risk: moderate)  05/08/08 Comment


Edwards Lifesciences (EW): Price cycles in bullish 'flag' formation Graphic_rating_buy EW
+42.30%
in 542 days

Filed under: Earnings reports, Baxter Intl (BAX), Technical Analysis, Stocks to Buy

Edwards Lifesciences Corporation (NYSE: EW) provides products and technologies designed to treat cardiovascular diseases. Offerings include tissue heart valves, valve repair products, heart monitoring equipment, central venous access devices and cardiac surgery system products. The company sells its goods through a direct sales force and independent distributors worldwide. Formerly part of Baxter International (NYSE: BAX), the firm was a year 2000 spin-off.

<>Edwards surprised the Street late last month, when it...
By  Larry Schutts   (-17.89%  risk: moderate)  05/16/08 Comment


Get free stock alert for EW:
Your Email Address:


The Bull Case on Edwards LifeSciences Graphic_rating_buy EW
Cc_logo
49%
 +43.26%
in 550 days

Edwards LifeSciences (EW) is an interesting small/mid cap play in this market. First off, the company provides products and technologies designed to treat cardiovascular diseases. It focuses primarily on heart valve disease, peripheral vascular disease, and critical care technologies.

<!--more--><>On April 22, the company raised its full-year sales and earnings guidance, citing strength in each of its product lines and reaping benefits from a weak dollar. The company expects profit between $2.45 and $2.53, a 13 cents-per-share increase in the range. Sales are expected to range from $1.21 bil...
By  The Correct Call   (+0.02%  risk: moderate)  05/08/08 Comment





People Bullish on EW

Statistician
Analyst
N/A
11 mos ago

Art
Analyst
N/A
11 mos ago

kdornbusch
Analyst
34%
about 1 year ago

Foto
Marian Filo
Principal
62%
about 1 year ago

Larry Schutts
Tracked Blogger
29%
about 1 year ago


People Bearish on EW

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.56% 369
2 Gerald Greene 18.14 +69.43% 206
3 stockmarketfunding.com 17.66 +25.71% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.75% 34


POPULAR STOCKS
Symbol Company Name Sentiment
AAPL Apple Computer Inc
CSCO Cisco Systems Inc
BA The Boeing Company
AMZN Amazoncom Inc
C Citigroup Inc
PG The Procter & Gamble Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on EW


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Edwards Lifesciences Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch